magazine 31 Oct 2019
Want to learn which areas of the market did best heading into and coming out of the most recent market sell-offs? Shares has the answers.
Find out what a looming UK election might mean for the markets.
Also this week: the transformation afoot at pharmaceutical giant GlaxoSmithKline and the funds exposed to higher risk dividends.
Discover what a blockbuster bid in the luxury goods space says about the sector and why alternative assets are in demand.
Shares also takes a detailed look at Scottish Investment Trust.
The sectors which recover quickest from a sell-off... and stand tallest in a downturn
Three things the Franklin Templeton Emerging Markets Equity team are thinking about today
Corporate tax cuts are a potential catalyst to get the economy back on track in the short term
Will a vote provide the clarity on the UK’s relationship with the EU investors are craving?
Mooted deal demonstrates the attractions of the high-end brands
Rising provisions for bad loans and poor investment banking returns crimp returns
Pharma giant hopes investing in cancer drugs and spinning-off consumer healthcare can re-invigorate its growth profile
New product launches show asset managers are looking outside more traditional areas of investing.
Patience is required to profit from the fund’s contrarian approach
There is a well established hierarchy of risk and return from shares, bonds and cash
Highlighting the funds with exposure to stocks with skinny dividend cover
A new code draws the spotlight on how big investors engage with companies
What the performance of different market groupings can tell us
As with stocks, liquidity is a key factor for retail investors
The market is underestimating the financial benefits from big acquisition
Why a big US acquisition has transformed the retailer’s growth prospects
We’re sticking with this value-oriented trust despite recent gains
ID technology expert remains a unique UK and international story